000 01526 a2200385 4500
005 20250513080634.0
264 0 _c19930408
008 199304s 0 0 eng d
022 _a0271-9142
024 7 _a10.1007/BF00920635
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChu, E
245 0 0 _aSuppression of the development of tumoricidal function in gamma interferon-treated human peripheral blood monocytes by lipopolysaccharide: the role of cyclooxygenase metabolites.
_h[electronic resource]
260 _bJournal of clinical immunology
_cJan 1993
300 _a49-57 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aCell Death
_xdrug effects
650 0 4 _aCyclooxygenase Inhibitors
_xpharmacology
650 0 4 _aCytotoxicity, Immunologic
_xdrug effects
650 0 4 _aDinoprostone
_xbiosynthesis
650 0 4 _aHumans
650 0 4 _aImmune Tolerance
_xdrug effects
650 0 4 _aIndomethacin
_xpharmacology
650 0 4 _aInterferon-gamma
_xpharmacology
650 0 4 _aLeukocytes, Mononuclear
_xcytology
650 0 4 _aLipopolysaccharides
_xpharmacology
650 0 4 _aMacrophage Activation
_xdrug effects
650 0 4 _aProstaglandin-Endoperoxide Synthases
_xmetabolism
650 0 4 _aTime Factors
700 1 _aCasey, L C
700 1 _aHarris, J E
700 1 _aBraun, D P
773 0 _tJournal of clinical immunology
_gvol. 13
_gno. 1
_gp. 49-57
856 4 0 _uhttps://doi.org/10.1007/BF00920635
_zAvailable from publisher's website
999 _c8444316
_d8444316